Skip to main content
All lobbying filings

Siemens Medical Solutions USA, Inc.

Siemens Medical Solutions USA, Inc. filed a Q2 report for Siemens Medical Solutions USA, Inc. on July 17, 2025.

Lobbying for Siemens Medical Solutions USA, Inc.

As filed: SIEMENS MEDICAL SOLUTIONS USA, INC for SIEMENS MEDICAL SOLUTIONS USA, INC.

All filings by Siemens Medical Solutions USA, Inc. · Everything Siemens Medical Solutions USA, Inc. has reported

 Amended
The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jul 28, 2026.
 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 17, 2025
Expenses
$770,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 9
Health Issues

Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to data privacy and transparency.

Medicare/Medicaid

S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.

Budget/Appropriations

H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.

Taxation/Internal Revenue Code

H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.

Trade (domestic/foreign)

Issues related to medical supply chains and procurement; and Issues related to international trade

Tariff (miscellaneous tariff bills)

Issues related to tariffs and supply chain resilience.

Defense

H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.

Medical/Disease Research/Clinical Labs

Issues related to NIH funding; and Issues related to ARPA-H Funding.

Natural Resources

Issues related to critical minerals supply chains and production.

 Bills named in this filing 5
  • S. 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • S. 1399
    Health Tech Investment Act
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 4121
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
  • H.R. 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem